Search

Your search keyword '"Schouten, Harry C."' showing total 19 results
Start Over Author "Schouten, Harry C." Publication Year Range Last 3 years
19 results on '"Schouten, Harry C."'

3. Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP

Author

Onida, Francesco, Sbianchi, Giulia, Radujkovic, Aleksandar, Sockel, Katja, Kröger, Nicolaus, Sierra, Jorge, Socié, Gerard, Cornelissen, Jan, Poiré, Xavier, Raida, Luděk, Bourhis, Jean Henri, Finke, Jürgen, Passweg, Jakob, Salmenniemi, Urpu, Schouten, Harry C., Beguin, Yves, Martin, Sonja, Deconinck, Eric, Ganser, Arnold, Zver, Samo, Lioure, Bruno, Rohini, Radia, Koster, Linda, Hayden, Patrick, Iacobelli, Simona, Robin, Marie, and Yakoub-Agha, Ibrahim

Published
2022
Full Text
View/download PDF

5. Nutrition-related problems, nutritional support practices and barriers to adherence to nutritional guidelines during intensive treatment for acute myeloid leukemia: Patients' and hematology nurses’ perspectives and experiences

Author

van Lieshout, Rianne, Lize, Nora, Tick, Lidwine W., van Deursen, Judith, Driessen, Eline, Janssen, Tina, Custers, Stephanie, Kranenburg, Suzanne, van der Lee, Debbie, Koene, Harry R., Beckers, Erik A.M., Schouten, Harry C., and Beijer, Sandra

Published
2022
Full Text
View/download PDF

6. Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Author

Robin, Christine, Cordonnier, Catherine, Tridello, Gloria, Knelange, Nina, Xhaard, Alienor, Chantepie, Sylvain, Tanguy-Schmidt, Aline, Schouten, Harry C., Yeshurun, Moshe, Rocha, Vanderson, Srour, Micha, Kröger, Nicolaus, Ledoux, Marie-Pierre, Dalgaard, Jakob, Thiebaut, Anne, Giardino, Stefano, Calore, Elisabetta, Zuckerman, Tsila, Groll, Andreas H., Raida, Ludek, Avcin, Simona, Vicent, Marta Gonzalez, Kaare, Ain, Drozd-Sokolowska, Joanna, Turlure, Pascal, Bretagne, Stéphane, Mikulska, Malgorzata, Camara, Rafael de la, Cesaro, Simone, and Styczynski, Jan

Published
2024
Full Text
View/download PDF

7. Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

Author

Robin, Christine, primary, Cordonnier, Catherine, additional, Tridello, Gloria, additional, Knelange, Nina, additional, Xhaard, Alienor, additional, Chantepie, Sylvain, additional, Tanguy-Schmidt, Aline, additional, Schouten, Harry C, additional, Yesherun, Moshe, additional, Rocha, Vanderson, additional, Srour, Micha, additional, Kröger, Nicolaus, additional, Ledoux, Marie-Pierre, additional, Dalgaard, Jakob, additional, Thiebaut, Anne, additional, Giardino, Stefano, additional, Calore, Elisabetta, additional, Zuckerman, Tsila, additional, Groll, Andreas H, additional, Raida, Ludek, additional, Avcin, Simona, additional, Vicent, Marta Gonzalez, additional, Kaare, Ain, additional, Drozd-Sokolowska, Joanna, additional, Turlure, Pascal, additional, Bretagne, Stéphane, additional, Mikulska, Malgorzata, additional, Camara, Rafael de la, additional, Cesaro, Simone, additional, and Styczynski, Jan, additional

Published
2023
Full Text
View/download PDF

8. Changes in nutritional status and associations with physical and clinical outcomes in acute myeloid leukemia patients during intensive chemotherapy

Author

van Lieshout, Rianne, Tick, Lidwine W., Beckers, Erik A. M., Biesbroek, Willemijn, Dieleman, Jeanne P., Dijkstra, Myrthe, Groenesteijn, Wanda, Koene, Harry R., Kranenburg, Suzanne, van der Lee, Debbie, van der Put - van den Berg, Liesbeth, Rademakers, Nicky, Regelink, Josien C., van Tilborg, Claudia J., Westerweel, Peter E., de Zeeuw, Sandra, Schouten, Harry C., and Beijer, Sandra

Abstract

Background/Objectives: Patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) often receive medical nutrition therapy (MNT) during intensive remission-induction treatment. Since little is known about changes in nutritional status, specifically body composition, in this patient population, these changes and their associations with physical and clinical outcomes were assessed. Subjects/Methods: In this multicenter prospective observational study, newly diagnosed AML/MDS patients who received intensive remission-induction chemotherapy, routine dietary counseling by a dietician and MNT immediately upon inadequate nutritional intake, were included. At treatment initiation and discharge, nutritional status, including Patient-Generated Subjective Global Assessment (PG-SGA)-scores and body composition, physical outcomes and fatigue were assessed. Associations of nutritional status/body composition with physical outcomes, fatigue, fever duration, number of complications, time to neutrophil engraftment and hospital length of stay (LOS) (collected from medical records) were examined using multiple regression analysis. Results: In >91% of the 126 AML/MDS patients included, nutritional intake was adequate, with 61% receiving MNT. Nevertheless, body weight decreased significantly (p< 0.001) and mainly consisted of a loss of muscle/fat-free mass (FFM) (p< 0.001), while fat mass (FM) remained unchanged (p-value range = 0.71–0.77). Body weight and waist circumference showed significant negative associations with fever duration and/or number of complications. Significant positive associations were found between mid-upper arm muscle circumference (MUAMC) and physical functioning and between PG-SGA-scores and fatigue. Body weight and MUAMC were also negatively associated with LOS. Conclusion: Despite MNT in AML/MDS patients undergoing intensive chemotherapy, muscle/FFM decreased while FM remained unchanged. Maintenance of nutritional status was associated with improved physical and clinical outcomes.

Published
2024
Full Text
View/download PDF

9. Supplemental Table 1 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

10. Supplementary Data from Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

Author

Kim, Haesook T., primary, Ahn, Kwang Woo, primary, Hu, Zhen-Huan, primary, Davids, Matthew S., primary, Volpe, Virginia O., primary, Antin, Joseph H., primary, Sorror, Mohamed L., primary, Shadman, Mazyar, primary, Press, Oliver, primary, Pidala, Joseph, primary, Hogan, William, primary, Negrin, Robert, primary, Devine, Steven, primary, Uberti, Joseph, primary, Agura, Edward, primary, Nash, Richard, primary, Mehta, Jayesh, primary, McGuirk, Joseph, primary, Forman, Stephen, primary, Langston, Amelia, primary, Giralt, Sergio A., primary, Perales, Miguel-Angel, primary, Battiwalla, Minoo, primary, Hale, Gregory A., primary, Gale, Robert Peter, primary, Marks, David I., primary, Hamadani, Mehdi, primary, Ganguly, Sid, primary, Bacher, Ulrike, primary, Lazarus, Hillard, primary, Reshef, Ran, primary, Hildebrandt, Gerhard C., primary, Inamoto, Yoshihiro, primary, Cahn, Jean-Yves, primary, Solh, Melhem, primary, Kharfan-Dabaja, Mohamed A., primary, Ghosh, Nilanjan, primary, Saad, Ayman, primary, Aljurf, Mahmoud, primary, Schouten, Harry C., primary, Hill, Brian T., primary, Pawarode, Attaphol, primary, Kindwall-Keller, Tamila, primary, Saba, Nakhle, primary, Copelan, Edward A., primary, Nathan, Sunita, primary, Beitinjaneh, Amer, primary, Savani, Bipin N., primary, Cerny, Jan, primary, Grunwald, Michael R., primary, Yared, Jean, primary, Wirk, Baldeep M., primary, Nishihori, Taiga, primary, Chhabra, Saurabh, primary, Olsson, Richard F., primary, Bashey, Asad, primary, Gergis, Usama, primary, Popat, Uday, primary, Sobecks, Ronald, primary, Alyea, Edwin, primary, Saber, Wael, primary, and Brown, Jennifer R., primary

Published
2023
Full Text
View/download PDF

11. Supplemental Figure 1 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

12. Supplemental Table 2 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

14. Supplemental Table 3 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

15. Supplemental Table 4 from Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia

Author

Boyiadzis, Michael, primary, Arora, Mukta, primary, Klein, John P., primary, Hassebroek, Anna, primary, Hemmer, Michael, primary, Urbano-Ispizua, Alvaro, primary, Antin, Joseph H., primary, Bolwell, Brian J., primary, Cahn, Jean-Yves Y., primary, Cairo, Mitchell S., primary, Cutler, Corey S., primary, Flowers, Mary E., primary, Gale, Robert P., primary, Herzig, Roger, primary, Isola, Luis M., primary, Jacobsohn, David A., primary, Jagasia, Madan H., primary, Klumpp, Thomas R., primary, Lee, Stephanie J., primary, Petersdorf, Effie W., primary, Santarone, Stella, primary, Spellman, Stephen R., primary, Schouten, Harry C., primary, Verdonck, Leo F., primary, Wingard, John R., primary, Weisdorf, Daniel J., primary, Horowitz, Mary M., primary, and Pavletic, Steven Z., primary

Published
2023
Full Text
View/download PDF

16. Supplementary Data from Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

Author

Baron, Frédéric, primary, Labopin, Myriam, primary, Ruggeri, Annalisa, primary, Cornelissen, Jan J., primary, Meijer, Ellen, primary, Sengeloev, Henrik, primary, Niederwieser, Dietger, primary, De Groot, Marco R., primary, Schouten, Harry C., primary, Milpied, Noel, primary, Blaise, Didier, primary, Savani, Bipin N., primary, Gluckman, Eliane, primary, Mohty, Mohamad, primary, and Nagler, Arnon, primary

Published
2023
Full Text
View/download PDF

18. Long-term effects after stem cell transplantation identified: design of the MOSA study

Author

Wauben, Bianca, van Yperen, Nicole C, van der Poel, Marjolein Wm, Köhler, Sebastian, van Greevenbroek, Marleen Mj, Schouten, Harry C, Interne Geneeskunde, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Hematologie (9), Psychiatrie & Neuropsychologie, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, and RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome

Subjects
MARROW TRANSPLANTATION, SURVIVORS, COMPLICATIONS, LATE MORTALITY, Cohort studies, Hematopoietic stem cell transplantation, Study design, FOLLOW-UP, General population controls, Long-term adverse effects
Abstract

OBJECTIVE: The MOSA study (Maastricht Observational study of late effects after Stem cell trAnsplantation) aims to study the prevalence of adverse health effects in hematopoietic stem cell transplantation (HCT) survivors compared to a matched cohort, representing the general population. STUDY DESIGN AND SETTING: The MOSA study is a matched cohort study, nested within a large prospective cohort, The Maastricht Study. Participants of The Maastricht Study serve as a reference group matched on age, sex and education to compare MOSA participants to the general population. In both studies, the same study protocol and extensive phenotyping measurements are used. RESULTS: HCT survivors: 539 survivors were invited of which, so far 123 (23%) participants completed the study assessments. Data will be analyzed and published separately. REFERENCE GROUP: For each MOSA participant, four reference cases were matched. After matching, both groups are comparable with respect to age, sex and education. CONCLUSION: To our knowledge, this is the first study conducting such detailed phenotyping in HCT survivors. Comparison with a large reference group provides essential information about late effects of HCT and associated risk factors. This may improve screening and prevention strategies, potentially leading to a positive impact on morbidity, mortality and quality of life.

Published
2022

19. Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study

Author

Bejanyan, Nelli, Zhang, Meijie, Bo-Subait, Khalid, Brunstein, Claudio, Wang, Hailin, Warlick, Erica D., Giralt, Sergio, Nishihori, Taiga, Martino, Rodrigo, Passweg, Jakob, Dias, Ajoy, Copelan, Edward, Hale, Gregory, Gale, Robert Peter, Solh, Melhem, Kharfan-Dabaja, Mohamed A., Diaz, Miguel Angel, Ganguly, Siddhartha, Gore, Steven, Verdonck, Leo F., Hossain, Nasheed M., Kekre, Natasha, Savani, Bipin, Byrne, Michael, Kanakry, Christopher, Cairo, Mitchell S., Ciurea, Stefan, Schouten, Harry C., Bredeson, Christopher, Munker, Reinhold, Lazarus, Hillard, Cahn, Jean-Yves, van Der Poel, Marjolein, Rizzieri, David, Yared, Jean A., Freytes, Cesar, Cerny, Jan, Aljurf, Mahmoud, Palmisiano, Neil D., Pawarode, Attaphol, Bacher, Vera Ulrike, Grunwald, Michael R., Nathan, Sunita, Wirk, Baldeep, Hildebrandt, Gerhard C., Seo, Sachiko, Olsson, Richard F., George, Biju, de Lima, Marcos, Hourigan, Christopher S., Sandmaier, Brenda M., Litzow, Mark, Kebriaei, Partow, Saber, Wael, and Weisdorf, Daniel

Abstract

•Myeloablative conditioning (MAC) results in lower relapse and better disease-free survival (DFS) after hematopoietic cell transplantation for acute myelogenous leukemia (AML)/myelodysplastic syndrome (MDS) with low/intermediate-risk Disease Risk Index (DRI).•MAC and RIC regimens yield similar DFS and overall survival for AML/MDS with high/very high-risk DRI.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results